These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2907641)

  • 1. The problem of influencing specific or unspecific emotional states by drugs: effects of a tranquilizer and two beta-blocking agents under noise conditions.
    Pohl J; Janke W; Erdmann G; Capek D
    Pharmacopsychiatry; 1988 Nov; 21(6):350-2. PubMed ID: 2907641
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the emotional effects of a beta-adrenergic blocking agent and a tranquilizer under different situational conditions. I. Anxiety-arousing situations.
    Erdmann G; Janke W; Köchers S; Terschlüsen B
    Neuropsychobiology; 1984; 12(2-3):143-51. PubMed ID: 6527756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiovascular effects of propanolol, alprenolol, oxprenolol and CS-359 during halothane anesthesia (author's transl)].
    Kubota M; Gotho Y; Furukawa K
    Masui; 1979 Aug; 28(8):797-804. PubMed ID: 43404
    [No Abstract]   [Full Text] [Related]  

  • 4. [Psychological-experimental study on the effects of tranquilizers (diazepam and a drug under investigation) considering personality variables (author's transl)].
    Boucsein W
    Arzneimittelforschung; 1976; 26(6):1138-41. PubMed ID: 989400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral toxicity of psychotropic drugs. 3. Effects on perceptual and cognitive functions. IV. Effects on emotional (mood) states.
    DiMascio A; Giller DR; Shader RI
    Conn Med; 1968 Oct; 32(10):771-5. PubMed ID: 4879067
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of tranquilizing agents and cardioselective beta-receptor blockaders on cardiovascular stress reaction].
    Schierl W; Schöning M; Kinadeter H; Lohmöller G; Lydtin H
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1212-5. PubMed ID: 19896
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of a beta blockader (SD/1601) associated with a tranquilizing agent (Camazepam) on systemic and coronary hemodynamic modifications due to induced emotional stress in the conscious dog].
    Brusoni B; Merlo L; Marchetti G
    Boll Soc Ital Biol Sper; 1977 Mar; 53(6):445-9. PubMed ID: 20907
    [No Abstract]   [Full Text] [Related]  

  • 8. A multidimensional concept for measuring CNS effects of beta-adrenoceptor blocking agents in human pharmacology.
    Wagner W; Ott H; Herrmann WM; McDonald RJ; Berzewski B
    Int J Clin Pharmacol Ther Toxicol; 1981 Jan; 19(1):23-33. PubMed ID: 6110635
    [No Abstract]   [Full Text] [Related]  

  • 9. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
    Kulig A; Kostka-Trabka E; Gryglewski R
    Pol J Pharmacol Pharm; 1973; 25(1):85-90. PubMed ID: 4149575
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
    Horii D; Kawada T; Takeda K; Imai S
    Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of isoproterenol activation of adenylate cyclase by metoprolol, oxprenolol, and the para isomer of oxprenolol.
    Petrack B; Czernik AJ
    Mol Pharmacol; 1976 Mar; 12(2):203-7. PubMed ID: 4723
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the effect of oxprenolol on experimentally induced anxiety (author's transl)].
    Liu KS; Debus G; Janke W
    Arzneimittelforschung; 1978; 28(8):1305-6. PubMed ID: 37852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of cardiovascular responses to emotional stress in preventive cardiology (author's transl)].
    Slabý A; Frantík E; Horváth M; Josífko M
    Cas Lek Cesk; 1981 Nov; 120(46):1393-8. PubMed ID: 6119155
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative study of the activity of beta-adrenoceptor antagonists in man.
    Taylor SH; Thadani U; Davidson C; singleton W; Myint S
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):305-6. PubMed ID: 240783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacoclinical study of oral butofilolol in arterial hypertension. Effects on heart rate, blood pressure and the renin-angiotensin system].
    Martinand A; Corvol P; Milliez P
    Therapie; 1983; 38(3):265-9. PubMed ID: 6137087
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemodynamic action of talinolol (Cordanum, 02-115), a new beta-receptor blocking substance, in man].
    Wolf P; Feller K; Femmer K
    Pharmazie; 1975 Oct; 30(10):678-81. PubMed ID: 696
    [No Abstract]   [Full Text] [Related]  

  • 17. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K; Kubota M; Odashiro M; Yasuda K; Goto Y
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract]   [Full Text] [Related]  

  • 18. [Polygraphic studies in subjects of different ages following a single dose of beta-adrenergic inhibitors].
    Sawiński J
    Pol Tyg Lek; 1973 Nov; 28(46):1803-5. PubMed ID: 4149218
    [No Abstract]   [Full Text] [Related]  

  • 19. [Smoking and beta adrenergic receptor blockade].
    Carlsen JE; Svendsen TL; Christensen NJ; Trap-Jensen J
    Ugeskr Laeger; 1980 Feb; 142(8):504-8. PubMed ID: 6102813
    [No Abstract]   [Full Text] [Related]  

  • 20. [Structure-activity relationship of phenoxyalkanolamine derivatives with selective beta 1-receptor blocking action].
    Femmer K
    Pharmazie; 1975 Oct; 30(10):638-42. PubMed ID: 687
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.